Iradimed (IRMD) FCF Payout Ratio Growth (1y) (2023 - 2026)
Iradimed (IRMD) FCF Payout Ratio Growth (1y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 157.80 Bn | 151.14 Bn | 6.27 Bn | 9.00% |
| 2 | Stryker | 115.54 Bn | 112.66 Bn | 3.81 Bn | -67.77% |
| 3 | Medtronic | 103.44 Bn | 95.27 Bn | 5.76 Bn | -7.45% |
| 4 | Boston Scientific | 72.38 Bn | 71.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 49.76 Bn | 46.09 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.53 Bn | 28.42 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 29.51 Bn | 27.44 Bn | 1.98 Bn | -51.96% |
| 8 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 9 | Steris | 20.69 Bn | 20.27 Bn | 697.10 Mn | 9,472.45% |
| 10 | Iradimed | 1.21 Bn | 1.16 Bn | 16.81 Mn | -91.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -91.08% |
| Dec 31, 2025 | 12.93% |
| Sep 30, 2025 | -17.41% |
| Jun 30, 2025 | 46.16% |
| Mar 31, 2025 | 64.58% |
| Mar 31, 2024 | 129.22% |
| Mar 31, 2023 | -174.78% |